Maggie Fisher MRCVS, the parasitologist and chairman of ESCCAP (European Scientific Counsel Companion Animal Parasites), has highlighted studies which demonstrate an association between the common parasite, Toxocara spp. and human disease, and has called on the profession to help reduce the damaging and widespread effects of this parasite.
Maggie says that many in the profession may not be aware that Toxocara eggs aren't actually infective when they are first passed in an animal's stools, sometimes taking weeks to develop to this stage. Eggs persist long after pet waste has naturally washed away too, so the risk of infection still exists even in environments that appear to be clean and safe. Interestingly, there seems to be only a very loose (and according to some studies, entirely absent) link between owning a pet and an increased risk of human Toxocara infection, suggesting that most infections are acquired from the environment1,2 . Education of pet owners about responsible pet ownership, including appropriate worming and picking up their dog's waste quickly is essential to reduce this environmental infection risk.
The parasite's larval stages cause disease in humans as they migrate through body tissues, with retinal damage a previously well identified consequence. However, Maggie has identified studies which suggest a whole range of common conditions that may also be attributable to Toxocara infection. One study3 included 425 children displaying signs of a persistent cough and 1600 asymptomatic children as controls. Blood tests confirmed that a statistically significant 32% of the symptomatic group were positive for Toxocara antibodies, compared to just 17% of the asymptomatic control group. What's more, when given a week's course of an appropriate anthelmintic, the vast majority of symptomatic children had a greatly reduced and frequently absent requirement for inhaled corticosteroids to control their symptoms when re-examined by the study team a year later.
Numerous other studies from around the world have shown similar strong associations with asthma, allergies and epilepsy. One nationally representative US study even showed an alarming association with Toxocara infection and reduced cognitive function in children2 . Those that were positive for antibodies to the parasite on blood tests (proving prior exposure) scored significantly lower on tests assessing verbal and manual dexterity as well as maths and reading abilities2 .
So, what should veterinary staff and SQPs be telling clients? Maggie says you should be advising pet owners to worm pets regularly (at least four times a year) with an effective anthelmintic from an appropriately young age (2 weeks of age for puppies and 3 weeks of age for kittens, because transfer of the parasite to puppies before birth and to kittens via milk is a feature of the parasite lifecycle). Reducing pets' access to raw food and hunting activities can also help. This is in addition to more general recommendations including cooking food well and making sure children wash their hands before eating.
Maggie said: "Vets, nurses and SQPs are perfectly placed to make sure that pet owners are aware of the risks and take precautions to protect themselves and the wider general public."
For further information about effective control of Toxocara and a wide range of other companion animal parasites, visit www.esccapuk.org.uk. To view all the presentations from the 'Everyday Parasites' CPD day, visit www.esccapuk-cpd.co.uk.
References:
Idexx Laboratories has announced the addition of pradofloxacin (Veraflox, Bayer Animal Health) to the list of antibiotics that it tests samples sent for culture and sensitivity testing against.
The company says that in the past, only a small percentage of the 350-400 samples it processes every day included a specific request from veterinary surgeons to include sensitivity testing to pradofloxacin. The now-routine testing for pradofloxacin is a positive move toward better clinical outcomes in difficult cases, including specific indications such as wound infections, superficial and deep pyoderma, and in cases with infections resistant to other antibiotics.
Idexx says that as the only next generation fluoroquinolone, pradofloxacin has been shown to be the least likely veterinary fluoroquinolone to select for resistance1, giving vets a lower risk option, when they decide to use an antibiotic from this class.
Matt Jones, Microbiology Manager at Idexx Laboratories said: 'Removing the need to specifically request samples to be tested for sensitivity to pradofloxacin has streamlined the culture and sensitivity testing process for vets and will make it easier for them to adhere to good practice in antibiotic prescription.
"This is important, as antimicrobial resistance is an area of deep international concern. Idexx are pleased to be helping vets identify those cases for which pradofloxacin may be effective and believe that, where indicated, it will lead to improved compliance and excellent clinical outcomes with the added benefit of reducing the likelihood of selecting for resistance, when compared to older generation fluoroquinolones."
The company says this move is in line with BSAVA's PROTECT initiative, which stresses the importance of culture and sensitivity, especially when prescribing antibiotics of the fluoroquinlone class.
Reference
The sessions will be delivered by Andrew Kent, clinical director at Blaise and a small animal internal medicine specialist, Lara Dempsey, head of soft tissue surgery, Jacques Ferrerira, head of anaesthesia, Mike Farrell, head of orthopaedic surgery, and neurology clinician, Emma Suiter (pictured).
The talks will cover:
Client communication will also be covered, together with some orthopaedics for those with an interest in that area.
Andy said: “We’re building an incredible team at Blaise and are very excited at the prospect of sharing the specialist knowledge that our clinicians have with our wider veterinary community.
"Treating liver conditions can be incredibly complex and our educational programme presents an unrivalled opportunity to deep dive into this part of an animal’s body and how best to approach it.”
Tickets are available for £48 from https://www.ivcevidensiareferrals.com/Delivering-the-Best, with all profits going to the charity StreetVet.
Blaise Veterinary Referral Hospital in Longbridge is IVC’s first purpose-built pet hospital and will be open to accept referral patients from November 2023.
www.blaise-referrals.com
http://herbertsyard.com
Ceva Animal Health UK is now providing Logic Oral Hygiene Gel sample sachets to veterinary practices free of charge, to enable clients to try before they buy on their cat or dog
In addition, to help veterinary practices promote the importance of dental hygiene, new waiting room display materials are also available.
To obtain your free Logic sample sachets or waiting room display material, please telephone 01494 781510 or e-mail customerservicesuk@ceva.com.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
References
Kruuse UK has announced that it will be launching its new Android telemetric ECG system at BEVA 2011.
The original Televet 100 supports transmission of ECG data to a range of approx 100m (330ft), allowing recording and displaying of real time data only within a confined lunging or riding arena. By linking this system to a mobile network via 3G Android phone and a Windows 7 based tablet PC, the new Televet system overcomes this range limitation.
The new system requires the rider/horse to carry a 3G mobile phone which transmits data over the mobile internet, allowing the veterinary surgeon to display and record real time data on any PC/laptop with internet access or mobile internet connection. This also includes GPS information collected by the phone allowing the ECG, heart rate and velocity of the horse to be displayed in parallel.
The Android Telemetric ECG system is specifically targeted towards veterinary applications in the field of sports horses where extended range is particularly useful, such as endurance riding, three day eventing and racing.
Televet software can now also be integrated in Dicom infrastructures in practice for data capture and recording.
Sarah Stokes, Kruuse Equine Territory Manager said: "the flexibility and simplicity of the system along with immediate access to ECG data of patients will be an invaluable diagnostic tool for UK vets allowing vital support for patients and owners wherever they are."
Visitors to the Kruuse stand at BEVA 2011 will also have the chance to win an Acer ICONI W500 tablet worth £500.
Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.
Flexi4 contains a blend of four plant extracts, Curcumin, Yucca schidigera, Salix alba and Boswellia serrata, which the company says have been shown to have anti-inflammatory, anti-pyretic and analgesic properties as follows:
Mary King, Olympic three day eventing team silver medallist, said: "When performing at the highest level it's important that my horses' joints remain flexible and free of pain. Using Flexi4 has made them more resilient to aches and pains during intense training and I am confident when competing that my horses are feeling the benefit of this natural product, helping them to perform at their very best."
Flexi4 is an apple-flavoured gel that is fed as a once daily supplement. It doesn't contain any substances listed as prohibited by the FEI.* For more information, contact your Zoetis Account Manager, call 0845 300 8034 or email customersupportuk@zoetis.com.
*FEI prohibited substance list, 2013
Under the previous system, complaints made about a veterinary surgeon or veterinary nurse would, at Stage One, be considered by a Case Examiner Group (CEG) which would determine if there was an arguable case of serious professional misconduct.
If the CEG found there was an arguable case, it would then refer it to Stage Two of the process for consideration by the Preliminary Investigation Committee.
The CEG stage of the process has now been replaced by Stage One Preliminary Investigation Committees which, rather than using the ‘arguable case’ threshold, will consider from the outset whether there is a realistic prospect that the alleged conduct constitutes serious professional misconduct and that there is sufficient evidence.
The new Stage One Preliminary Investigation Committees will comprise members of the professions and lay people, and will be assisted in their investigations by an RCVS Case Manager who will also be the first point of contact for those raising concerns, witnesses and respondents in the case.
Eleanor Ferguson, RCVS Registrar and Director of Legal Services, said: “By keeping to one consistent threshold for serious professional misconduct throughout the concerns investigation process, we hope that these changes will help to simplify our investigations while still ensuring that the process remains robust and thorough.
"We also hope that, in time and when the changes are fully bedded in, we may also see a swifter resolution to some cases, as concerns that may previously been referred on to Stage Two of the process can now be closed at Stage One.”
If a Stage One Preliminary Investigation Committee cannot close a case it will refer it on to a Stage Two Preliminary Investigation Committee.
This will gather additional information and evidence and then determine if there is a realistic prospect of finding serious professional misconduct and if it is in the public interest for the case to go to Stage Three - a full, public Disciplinary Committee hearing.
Eleanor added: “The introduction of these new stages is the first step in the programme of reform of our concerns investigation and disciplinary processes.
"Next year we will be looking to introduce our Charter Case Protocol which will be a way of resolving some less serious cases of alleged misconduct where it would not necessarily be in the public interest to hold a full Disciplinary Committee hearing.”
www.rcvs.org.uk/concerns
This year, there have been over 30,000 nominations for the awards.
The finalists this year are:
Vet of the YearAndrew Hayes, Towcester Equine Vets, TowcesterClare McCabe (pictured right), Claymill Veterinary Clinic, CookstownLaurence Behrens, Goddard Veterinary Group, Dagenham
Vet Nurse of the YearCaroline Jones, Battle Flatts Veterinary Surgery, YorkHelen Rooney, Pet Blood Bank, LoughboroughLesley Ramsey, Debenham Veterinary Practice, Stowmarket
Practice Support Staff of the YearRhiannon Lewis, Streatham Hill Vets, StreathamLaura Cameron, Lomond Veterinary Clinic, HelensburghLouise O’ Reilly, Vets4Pets, Llanrumney
Practice Manager of the YearKristen Lorimer, Blue House Veterinary Centre, Stoke-on-TrentLouise Newman, Blue Cross Vets, MertonNicki Ridgeway, Vets4Pets, Ridgeway
Practice of the YearHollybank Veterinary Centre, NorthwichLanes Vets, PoultonMilfeddygon Williams Vets, Gwynedd
The awards will be hosted at the Kimpton Clocktower Hotel, Manchester on 23rd March.
Bella von Mesterhazey, Sales & Marketing Director at Petplan, said: “This year’s finalist line-up includes an outstanding array of veterinary professionals and practices, and Petplan is delighted to be celebrating the highest achievements in pet healthcare once again."
A recent survey of nurses attending Hill's nurse roadshows has identified that just over 20 per cent of nurses pay for their own CPD. Although no claims have been made regarding how representative the sample is of the general nursing population, the survey by Hill's Pet Nutrition mirrors the results of a recent RVCS survey.
Adrian Pratt, Veterinary Affairs Manager at Hill's said: "It comes as no great surprise to find that nurses are so dedicated to doing a good job that they will even fund their learning themselves and it's great that round 80 per cent are having their CPD paid for. It is a little depressing to find that some of the practices they work in are unable to support nurses in their efforts, perhaps because of the economic situation. We launched our Veterinary Nutrition Academy with the aim of offering easy to access CPD, free or at very low cost. Practice members can register free and I'd really encourage practice principals and practice managers to take a look at www.myhillspet.com/vna to see how much is available for negligible or very little expenditure. The credit crunch is affecting lots of people and practices but if we can use any down time available to improve skills and knowledge, that has got to be a healthy response."
Bonny Millar, President of the BVNA said: "Some employers may still be unaware that CPD is now compulsory for the RVN but a recent RCVS ‘Survey of the Veterinary Nursing Profession 2008', found that qualified VNs were not finding it difficult to meet the required 45 hours of CPD over 3 years. Those who took part in the survey said that they averaged just over 3 days in the last 12 months, with 84% of those surveyed saying all or most was paid for by the employer. As there is no obligation for the employer to pay for CPD, it is good to know that so many are doing so but it is also important that nurses can demonstrate that any newly gained knowledge will be used to provide a better service to their patients and practice."
This was a view echoed by Sarah Hibbert, President of VPMA: "It would seem logical that relevant CPD which has a benefit to both the practice and individual should be considered in a structured fashion and in light of these findings it would be appropriate for practices revisit their CPD policies to ensure they are fair and reasonable to all parties concerned."
The Hill's survey also showed that just under 30 per cent of nurses have their own CPD allowance provided by the practice. This suggests that about half of the nurses in the UK are to a large extent basing their CPD on self-directed learning. One of the champions of self-directed learning, Malcolm Knowles, defines it as a process ‘... in which individuals take the initiative, with or without the help of others, in diagnosing their learning needs, formulating learning goals, identifying human and material resources for learning, choosing and implementing appropriate learning strategies, and evaluating learning outcomes.'
According to Adrian this could signal a positive step forwards, "On one hand self directed learners have been shown to be more proactive about learning, more motivated and more likely to retain and use what they do learn. However, there is a danger that a practice could be left with gaps in knowledge or skills unless there is some active intervention in the form of a review or guidance regarding the individual's particular training needs, those of the practice team as a whole and the appropriateness of individual courses. Those practices that allocate training allowances are to be congratulated on being forward thinking but it is worth remembering that conferring a training allowance does not involve abrogating responsibility for providing support, guidance and encouragement. We have taken care to introduce incentives for completion of Hill's VNA courses, not because we think that nurses need to be motivated by extrinsic rewards but because we should celebrate those who work hard to become better nurses."
Vetoquinol UK Ltd has launched a new flea and tick treatment for cats and dogs.
Flevox is a spot-on solution containing fipronil and comes in unique pack sizes of either single pipettes or large clinic packs of 36.
Product Manager Helen Walker said: "With only 55% of pet owners buying their flea and tick treatment from the vet, we recognise there is a huge opportunity to develop and grow this essential market. In the modern age the consumer expects maximum flexibility, and that is what we aim to provide with Flevox.
Whether it be persuading the price-conscious customer away from buying their flea treatments in supermarkets and the internet, or encouraging those who don't treat their pet at all to give it a try without breaking the bank, we're confident we can help grow flea treatment sales in practice."
Vetoquinol says it is supporting the new product with a range of materials dedicated to veterinary surgeries, providing incentives to encourage client bonding and repeat business with your practice.
Helen continued: "We have also teamed up with the fantastic charity Dogs for the Disabled by making a donation for every pipette of Flevox sold. We're really looking forward to raising the profile of this organisation where these amazing dogs give life changing independence to disabled people. We're confident the donation will strike a chord with clients and really engage them with the charity, the Flevox brand and the practice".
To find out more, contact your Vetoquinol territory manager or visit http://www.vetoquinol.co.uk/
The company says the challenge has been developed on the basis of recent research which found that despite 74% of vet-visiting pet owners believing in the value of preventative healthcare, more than half of active pet owners currently don’t see the vet as their primary source of information regarding pet health. Furthermore, those pet owners that fail to return for an annual preventative health consultation often cited their pet being healthy as the main reason.
The new scheme focuses on driving client compliance and footfall by developing the partnership between the vet and pet owner. MSD says it takes a more holistic approach to the relationship, focusing on the vet practice as the primary source of advice and information on all aspects of pet healthcare and wellbeing, whether the pet is healthy or sick.
Practices that register with their MSD Animal Health account manager will receive a toolkit to support their whole team in positioning the practice as a centre for expertise on preventative healthcare and wellbeing.
Caroline Darouj, Nobivac Brand Manager at MSD Animal Health said: :This Challenge is a step-change in terms of our work with vets and support for the practice-pet owner partnership. We are focusing on encouraging communications that highlight the value of the preventative healthcare visit going beyond the obvious benefits of vaccination and parasite control.
"We have recently heard in the news how by just having a conversation about obesity medical practitioners can be an effective catalyst for positive change with patients. It is our belief that changing the conversation and focusing on preventative health has the potential to create positive outcomes in pet health and wellbeing, as well as owner satisfaction and business outcomes."
MSD says the challenge goes beyond the important and widely recognised aspects of preventative healthcare such as vaccination, worming and ectoparasite control to embrace five principal wellbeing needs around care and companionship, feeding, the pet’s environmental, behavioural and preventative health needs. The toolkit will aim to increase the pet owner’s understanding of the value and benefit of annual preventative healthcare visits and develop the level of client engagement with practice staff.
Practices interested in further details should contact their MSD Animal Health Account Manager or call MSD Animal Health on +44 (0) 1908 685 556.
Following a nationwide search to find the UK’s top veterinary professionals for 2008 and judged by an independent panel of experts, Petplan has announced the final short-list for the Petplan Veterinary Awards to be presented on 3rd April in Birmingham.
Those short-listed for the four categories of the Petplan Veterinary Awards acknowledging achievement in the veterinary world include:
Vet of the Year Brian Faulkner of the Melton Veterinary Surgery, Woodbridge Linda Glenn of the Glenn Veterinary Clinic, Bangor Girish Thakral of the Blacks Veterinary Group, Dudley
Vet Nurse of the Year Louisa Baker of the Priors Leaze Veterinary Centre, Chichester Alison Devonshire of the Orwell Veterinary Group, Ipswich Mark Vince of The Animal Clinic, Catford
Vet Receptionist of the Year Margaret Coupe of the Hedge End Veterinary Health Centre, Southampton Margaret Gait of Cinque Ports Veterinary Associates, Lydd Sandie Rule of the Eastcott Veterinary Clinic, Swindon
Vet Practice of the Year Battle Flatts Veterinary Clinic, York Orwell Veterinary Group, Ipswich Woodlands Veterinary Clinic, Cheltenham
Goddards, the Greater London-based 46-branch, 3 hospital veterinary group has announced the move of its HQ to a new premises in a former police station in Woodford Green, Essex.
Twenty staff from the practice, including senior managers, the accounts and IT teams and the ProActive Pets Wellness Club, are now based at the new premises.
PC Philip Goddard of Woodford Green said: "After 60 years working within our hospital in Wanstead, our support teams had outgrown the office space available. The move provides a greatly enhanced working environment for them and has also freed up space in the hospital that will be used to improve facilities for staff there, including a new lecture room for our Nursing College and Training Department."
The new address is: Claygate House, Manor Road, Woodford Green, Essex IG8 8BX. Telephone: 020 8506 0703.
The event will deliver more than 130 hours of CPD, including a programme of five simultaneous live streams each day. Delegates will also have opportunities to network and socialise - with peers, colleagues and experts in chat rooms and breakout sessions, and with industry partners - such as event sponsor Hill’s Pet Nutrition - in the online exhibition hall.
Live content will be delivered via 24 content modules and a library of 100 on-demand webinars will support the 80 hours of live programming. Scientific content will be available on the platform for 30 days and then available to attendees via the BSAVA library.
For the first time nursing, clinical and business topics will be blended into modules from which delegates can select the content they need.
Professor Ian Ramsey, President of the BSAVA, said: "On the clinical side, we’re covering everything from chronic pain and neurology to cardiology and orthopaedics – whatever your interests, there will be something for you."
“Most sessions in the live programme will feature two speakers, each delivering short presentations followed by a live, audience-led conversation. This new approach means delegates can explore the multi-faceted disciplines of the small animal veterinary world and see the clinical challenges from different points of view and, most importantly, join in.
“Pre-recorded webinars support the live programme, enabling delegates to dip in at their leisure. We’ve also swapped traditional lengthy notes or MCQs, with practical resources such as client handouts or flowcharts for delegates to take back to their clinics”.
Congress will also be covering an update on sustainability issues through the module titled, ‘can the profession go green?’ On the practical business front, recruitment and retention will be discussed and keynote speaker Jenny Campbell, a former Dragon on BBC’s Dragon’s Den, will be sharing her experiences as an entrepreneur and business leader.
BSAVA Congress prices start at £99 +VAT. To register, visit www.bsavaevents.com
BSAVA has launched its Postgraduate Certificate website.
The site contains all of the online materials and activities which support the BSAVA postgraduate certificates. The BSAVA says students enrolled on the programmes will find it invaluable.
There are also sections of the site for those who have agreed to act as mentors for students enrolled on the programme, and exclusive material for BSAVA members who missed out on enrolment in 2012, but have pre-enrolled for 2013.
The BSAVA Postgraduate Certificate website may be found via the CPD section at http://www.bsava.com/ (direct link http://www.bsavaeducation.co.uk/). If you would like to know more about the BSAVA Postgraduate Certificate programmes, please email certificate@bsava.com.
BCF Technology will be offering a new imaging service at this year's BSAVA Congress.
The company is inviting delegates to have a comical caricature drawn on the first floor concourse area of the BSAVA exhibition hall, and then visit the BCF stands - 514 & 516 to collect a frame and hang it in your practice when you get back.
Kimberly Palgrave, BCF's new in-house vet (pictured right) said: "We wanted to do something new and innovative to support BSAVA this year, we are a veterinary imaging company and the caricatures at BSAVA are an innovative form of imaging. Come and talk to us about learning more about ultrasound and X-ray and see some of our new equipment such as the very affordable Vita CR X-ray system."
For more information about BCF at BSAVA visit http://www.bcftechnology.com/ or follow BCF at www.facebook.com/bcftechnology
Zoetis (maker of Cerenia, the anti-emetic) is using social media for its latest campaign to remind owners that vets have a solution for dogs that suffer from travel sickness.
The company highlights research which shows the problem is more common than one might think, with 62% of dogs experiencing travel sickness for the first time as puppies. What's more, 1/3rd of owners say they would travel with their dogs more often if they didn't get car sick.
Stephanie Smith, Marketing Manager for Cerenia said: "While less than half of vets in the UK report seeing at least one canine motion sickness case each month, we know that over one third (34%) of dogs that travel experience motion sickness. That's a lot of opportunity for vets to provide pets and owners with some relief."
To spread the word, the company has set up an educational microsite: www.nonstoptravelfun.co.uk which it is now promoting with an online social media campaign, including twitter #nonstoptravelfun and targeted bloggers and pet sites. The company has also been advertising the microsite on Facebook and Google, which I'm told has driven thousands of visitors over the past fortnight.
Stephanie added: "Motion sickness can impact the whole family, making travelling an unpleasant experience. Our new campaign aims to raise awareness for the issue and encourage pet owners to seek veterinary help for the problem, so they can enjoy non-stop travel fun, without the sickness."
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
Molar Ltd is launching a cross infection control product called VetroxxTM at this years' BSAVA Congress
VetroxxTM is a range of 100% natural disinfectant products approved by the Department of Health (HPA) for use as a hospital disinfectant and has been approved by the British Government's MAFF (now DEFRA) to control against outbreaks of significant agricultural diseases (e.g. Foot and Mouth Disease, Tuberculosis, Newcastle's Disease found in chickens & Swine Fever).
The range includes a convenient disinfectant hand gel, surface wipes and a multi-surface spray. According to Molar, VetroxxTM has been scientifically tested, proven to reduce microorganism numbers by up to 99.9998%, and kills most problem bugs, including: MRSA, Bird 'flu (H5N1), SARS, HIV, C diff and many others.
The range contains Citroxx®, a naturally-derived disinfectant made from orange pith. Molar says the product is both safe and highly biodegradable, and very kind on skin and surgery surfaces (such as examination tables, flooring and bench tops). The company adds that since Citroxx contains several antimicrobial elements, it is unlikely that resistance will develop.
During Congress, Molar will be challenging vets hand-washing skills using a special UVA (long wave UV) light box to highlight failures.
To nominate someone for inclusion in the showcase, visit: https://www.beva.org.uk/60-Faces
BEVA President Lucy Grieve said: "We are proud of BEVA’s heritage and want to recognise our 60th birthday by celebrating some of those who have made a significant difference to the equine veterinary community. We want you to help us identify the 60 individuals who you believe have truly inspired, influenced and progressed the equine veterinary profession for the better.”
Each of the nominated 60 faces will be highlighted on the website and on BEVA’s social media channels. Profile details will include career paths, workplaces and personal contributions to the equine veterinary profession.
Lucy added: "We have already started the list with Colonel John Hickman, Sue Dyson and Peter Rossdale. But there are hundreds of exceptional, deserving individuals who have made a huge difference to the equine veterinary profession and are worthy of our 60 Faces roll call."
The deadline for nominations is Friday 16th April 2021. All nominations are anonymous.
Q Fever is caused by the bacterium Coxiella burnetii, which can infect humans, cattle, goats, sheep and many other mammals, as well as reptiles, ticks and birds.
Known originally as Query fever, it was first identified in Australia in 1935 after an outbreak of disease in abattoir workers.
Ceva says half of UK dairy farms may be at risk of Q Fever1, 2.
The webinar, which will be presented by Jonathan Statham MA VetMB DCHP FRCVS (pictured right), an RCVS-registered specialist in cattle health and co-author of the ‘Dairy Herd Health’ textbook, will count towards 1.5 hours of CPD.
It will cover the UK prevalence of Q Fever in herds, its cause and transmission, together with identification and diagnostics.
It will also look at the variations between livestock species, disease prevention and its risk to humans as a zoonosis.
Jonathan said: "Q Fever is of much higher profile in many other parts of the world such as Australia and has been notifiable for some years with national testing programmes in a number of European countries such as Germany.
“Recently Q Fever has become notifiable in the UK and climate change is changing the future risk profile."
Renzo Di Florio, veterinary advisor at Ceva said: “The disease causes issues with reproduction and fertility and has the potential to have significant impact on livestock health and productivity.
"However, awareness is low amongst the farming industry.
“Our Q Fever webinar will help raise awareness of the disease and the preventative measures that can be put in place to help protect those working with livestock on a regular basis and reduce the impact of Q Fever on farms.
To register for the webinar or if you have further questions, e-mail cevauk-webinars@ceva.com
Available in packs of 56 (4 x 14 tablet blister packs), Lodisure tablets are divisible for accurate dosing.
The recommended starting dose is 0.125-0.25 mg amlodipine per kg bodyweight per day, which equates to half a tablet for cats weighing less than 4kg (and more than 2kg) and one tablet per day for cats weighing between 4kg and 8kg.
It can be administered directly to the cat or given with a small quantity of food.
Dechra companion animal brand manager, Sarah Musgrave, said: “Feline hypertension is very often part of a more complex diagnosis, therefore it is important that antihypertensive therapies are easy to dose and administer.
"Lodisure is a new, first-line, easy to dose and administer treatment to control systolic blood pressure in cats while the underlying primary cause is diagnosed and treated, which vets can rely on in their day-to-day practice.”
https://www.dechra.co.uk/products/cat/prescription/lodisure.
Eight vet students have been recognised for their exceptional work with the Intervet / Schering-Plough Animal Health Connect Bursary Awards, designed to provide financial assistance for students for elective research during their college years. Three main awards were made for projects focussing on laterality in dogs, stallion semen preservation, and developing a better understanding of wobbler syndrome in horses.
Charlotte Cockburn from the Royal Veterinary College (RVC) and Hayley Harwood from the Royal Dick School of Veterinary Studies (Edinburgh) were the joint winners of the main Bursary Award, while the RVC's Holly Claridge was presented with the inaugural Equine Award.
Charlotte's research investigated tests for laterality in dogs to determine if domestic dogs show a significant paw preference and to identify a test that can be used for this purpose by veterinary practices. The results showed a lateralisation bias in the dog population towards the left with no significant correlations between paw preference and the sex, age or breed of dog. In addition, the initiation of gait test used in the study was the only test that gained a response from 100% of the dogs.
Hayley set out to investigate the motility of stallion spermatozoa thawed at various rates and maintained for up to 24 hours with the aim of designing a protocol for the thawing of semen that would allow cooled transported frozen-thawed semen to be used effectively. The study showed that for total motility, thawing the straws at 72°C resulted in significantly higher motility than when compared with other treatments.
Holly's research aimed to describe the 3D anatomy of the cervical articular process joints in relation to the spinal cord and whether artificial distension of these joints, mimicking effusion, would cause the pouches of the joints to compress the spinal cord in the horse. The study concluded that in the absence of any other soft tissue or bony changes effusion of these joints is unlikely to cause spinal cord compression. However, given that these joints and the spinal cord are in close approximation, in the presence of other changes, an effusion may have the potential to cause compression.
While Charlotte, Hayley and Holly were the overall winners, five other students also received a Connect Bursary from Intervet / Schering-Plough Animal Health to fund their research. The Bursaries were awarded to Rebecca Johnson and Sharon Brown (Glasgow), Gabrielle Laing (Liverpool), Alex Torrance (Cambridge) and Amy Gordan (Bristol). Students were required to present their work to a judging panel from Intervet / Schering-Plough Animal Health, representatives from the veterinary schools and industry key opinion leaders. Two further Bursaries were also awarded to students from Nottingham.
David Hallas, General Manager at Intervet / Schering-Plough Animal Health said: "Being part of the Connect Bursary is intended to give veterinary students both the freedom to explore new ground as well as providing a taste of working in industry. The fact that we awarded a record number of Bursaries this year, elected joint winners and launched the new Equine Award is testament to the refreshingly high standard of work being undertaken by veterinary undergraduates."
BSAVA Congress was invaded by Orangemen this year to promote the Vet Charity Challenge (VCC) taking place on 15th September 2012.
Veterinary surgeons and industry colleagues are being encouraged to take part in the one day event in which teams of four will complete a series of physical tasks and puzzle-solving challenges. Teams can choose their own routes which include walking / running, cycling and kayaking stages and can make it as easy or hard as they like.
The Vet Charity Challenge is hoping to raise in excess of £20,000 for Hounds for Heroes; SPANA, and Pet Blood Bank. VCC says it will be a great PR opportunity for practices and an opportunity for team-building.
The event will take place at the Royal Agricultural College, Cirencester and all details may be found on www.vetcharitychallenge.co.uk or by phoning 01727 859259. The VCC will provide training guidelines and sponsorship forms. Places are limited so early booking is advisable. To be sure of a place, practices and business are urged to book their team of four by the deadline of Friday 29th June 2012.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets2.net and is supported by the VPMA, Mojo Consultancy and JCA Media Group.